Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Pheromone Biosynthesis Activating Neuropeptide Receptor (PBAN-R), also known as the Pyrokinin-2 Receptor (PK2-R), is a G protein-coupled receptor (GPCR) that serves as a master regulator of reproductive signaling in various insect species, particularly within the order Lepidoptera (UniProt: Q869B0). Upon activation by the PBAN ligand, the receptor initiates a signal transduction pathway that typically involves the mobilization of intracellular calcium, which in turn activates the enzymatic machinery required for sex pheromone biosynthesis in the pheromone gland (PubMed: 15518655). This physiological process is vital for mate attraction and the continuation of the species' life cycle. In the field of agricultural biotechnology, PBAN-R is considered a high-priority target for the development of next-generation biopesticides and mating disruption agents (PubMed: 12810625). By designing specific agonists or antagonists, researchers aim to manipulate insect behavior or suppress populations of agricultural pests like the corn earworm or silkworm (PubMed: 25445280). While PBAN-R does not have a direct therapeutic role in human medicine, it shares evolutionary lineage with mammalian Neuromedin U receptors, making it a subject of interest for comparative endocrinology and GPCR pharmacology studies. The development of PBAN-R ligands represents a shift toward more environmentally sustainable pest management practices, though challenges remain regarding species specificity and the environmental stability of peptide-based compounds.
Agonism of the receptor triggers a calcium-dependent signaling cascade that activates enzymes for pheromone production; antagonism prevents pheromone release and disrupts mating behavior.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pheromone biosynthesis activating neuropeptide receptor (PBAN-R) (PBAN-R).